Extended release Quetiapine Fumarate (Quetiapine XR) in acute and maintenance studies in Major Depressive Disorder (MDD): suicidality data

被引:0
|
作者
Weisler, R. [1 ]
Montgomery, S. A. [2 ]
Eriksson, H. A. [3 ]
Szamosi, J. [3 ]
机构
[1] Duke Univ, Med Ctr, Univ N Carolina Chapel Hill, Durham, NC USA
[2] Univ London, Imperial Coll Sch Med, London, England
[3] AstraZeneca R&D, Sodertalje, Sweden
关键词
D O I
暂无
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
引用
收藏
页码:45 / 46
页数:2
相关论文
共 50 条
  • [31] Randomized, Double-Blind Study of the Efficacy and Tolerability of Extended Release Quetiapine Fumarate (Quetiapine XR) Monotherapy in Elderly Patients with Major Depressive Disorder
    Katila, Heikki
    Mezhebovsky, Irina
    Mulroy, Amy
    Berggren, Lovisa
    Eriksson, Hans
    Earley, Willie
    Datto, Catherine
    AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY, 2013, 21 (08): : 769 - 784
  • [32] EXTENDED RELEASE QUETIAPINE FUMARATE IN MAJOR DEPRESSIVE DISORDER: ANALYSIS IN PATIENTS WITH ANXIOUS DEPRESSION
    Thase, Michael E.
    Demyttenaere, Koen
    Earley, Willie R.
    Gustafsson, Urban
    Udd, Mattias
    Eriksson, Hans
    DEPRESSION AND ANXIETY, 2012, 29 (07) : 574 - 586
  • [33] Efficacy and tolerability of extended release quetiapine fumarate (quetiapine XR) monotherapy in major depressive disorder: A randomized, placebo-controlled clinical trial (study 003)
    El-Khalili, Nizar
    Banov, Michael
    Bortnick, Brian
    Adson, David
    Datto, Catherine
    Raines, Shane
    Earley, Willie
    Brecher, Martin
    BIOLOGICAL PSYCHIATRY, 2008, 63 (07) : 297S - 297S
  • [34] EXTENDED-RELEASE QUETIAPINE FUMARATE (QUETIAPINE XR) VERSUS RISPERIDONE IN THE TREATMENT OF DEPRESSIVE SYMPTOMS IN SCHIZOPHRENIC OR SCHIZOAFFECTIVE PATIENTS
    Kasper, S.
    Di Fiorino, M.
    Montagnani, G.
    Trespi, G.
    EUROPEAN PSYCHIATRY, 2011, 26
  • [35] Extended-release quetiapine fumarate in the treatment of patients with major depressive disorder: adjunct therapy
    Weisler, Richard
    McIntyre, Roger S.
    Bauer, Michael
    EXPERT REVIEW OF NEUROTHERAPEUTICS, 2013, 13 (11) : 1183 - 1200
  • [36] The role of extended-release quetiapine fumarate monotherapy in the treatment of patients with major depressive disorder
    Weisler, Richard
    McIntyre, Roger S.
    EXPERT REVIEW OF NEUROTHERAPEUTICS, 2013, 13 (11) : 1161 - 1182
  • [37] Quetiapine Extended Release Adjunctive Treatment in Major Depressive Disorder
    Sanford, Mark
    CNS DRUGS, 2011, 25 (09) : 803 - 813
  • [38] Pharmacokinetic profile of the extended-release formulation of quetiapine fumarate (quetiapine XR): clinical implications
    Bui, Khanh
    Earley, Willie
    Nyberg, Svante
    CURRENT MEDICAL RESEARCH AND OPINION, 2013, 29 (07) : 813 - 825
  • [39] Sexual functioning in patients with major depressive disorder in randomized placebo-controlled studies of extended release quetiapine fumarate
    Clayton, Anita H.
    Locklear, Julie C.
    Svedsater, Henrik
    McIntyre, Roger S.
    CNS SPECTRUMS, 2014, 19 (02) : 182 - 196
  • [40] Extended-release quetiapine fumarate (quetiapine XR) as adjunctive therapy in major depressive disorder (MDD) in patients with an inadequate response to ongoing antidepressant treatment: a multicentre, randomized, double-blind, placebo-controlled study
    El-Khalili, Nizar
    Joyce, Mark
    Atkinson, Sarah
    Buynak, Robert J.
    Datto, Catherine
    Lindgren, Petter
    Eriksson, Hans
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2010, 13 (07): : 917 - 932